Christopher Schröder
University of Duisburg-Essen
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Christopher Schröder.
Nature Genetics | 2015
Alexander Schramm; Johannes Köster; Yassen Assenov; Kristina Althoff; Martin Peifer; Ellen Mahlow; Andrea Odersky; Daniela Beisser; Corinna Ernst; Anton Henssen; Harald Stephan; Christopher Schröder; Lukas C. Heukamp; Anne Engesser; Yvonne Kahlert; Jessica Theissen; Barbara Hero; Frederik Roels; Janine Altmüller; Peter Nürnberg; Kathy Astrahantseff; Christian Gloeckner; Katleen De Preter; Christoph Plass; Sangkyun Lee; Holger N. Lode; Kai Oliver Henrich; Moritz Gartlgruber; Frank Speleman; Peter Schmezer
Neuroblastoma is a malignancy of the developing sympathetic nervous system that is often lethal when relapse occurs. We here used whole-exome sequencing, mRNA expression profiling, array CGH and DNA methylation analysis to characterize 16 paired samples at diagnosis and relapse from individuals with neuroblastoma. The mutational burden significantly increased in relapsing tumors, accompanied by altered mutational signatures and reduced subclonal heterogeneity. Global allele frequencies at relapse indicated clonal mutation selection during disease progression. Promoter methylation patterns were consistent over disease course and were patient specific. Recurrent alterations at relapse included mutations in the putative CHD5 neuroblastoma tumor suppressor, chromosome 9p losses, DOCK8 mutations, inactivating mutations in PTPN14 and a relapse-specific activity pattern for the PTPN14 target YAP. Recurrent new mutations in HRAS, KRAS and genes mediating cell-cell interaction in 13 of 16 relapse tumors indicate disturbances in signaling pathways mediating mesenchymal transition. Our data shed light on genetic alteration frequency, identity and evolution in neuroblastoma.
Epigenetics & Chromatin | 2016
Stefan Wallner; Christopher Schröder; Elsa Leitão; Tea Berulava; Claudia Haak; Daniela Beißer; Sven Rahmann; Andreas S. Richter; Thomas Manke; Ulrike Bönisch; Laura Arrigoni; Sebastian Fröhler; Filippos Klironomos; Wei Chen; Nikolaus Rajewsky; Fabian Müller; Peter Ebert; Thomas Lengauer; Matthias Barann; Philip Rosenstiel; Gilles Gasparoni; Karl Nordström; Jörn Walter; Benedikt Brors; Gideon Zipprich; Bärbel Felder; Ludger Klein-Hitpass; Corinna Attenberger; Gerd Schmitz; Bernhard Horsthemke
BackgroundMonocyte-to-macrophage differentiation involves major biochemical and structural changes. In order to elucidate the role of gene regulatory changes during this process, we used high-throughput sequencing to analyze the complete transcriptome and epigenome of human monocytes that were differentiated in vitro by addition of colony-stimulating factor 1 in serum-free medium.ResultsNumerous mRNAs and miRNAs were significantly up- or down-regulated. More than 100 discrete DNA regions, most often far away from transcription start sites, were rapidly demethylated by the ten eleven translocation enzymes, became nucleosome-free and gained histone marks indicative of active enhancers. These regions were unique for macrophages and associated with genes involved in the regulation of the actin cytoskeleton, phagocytosis and innate immune response.ConclusionsIn summary, we have discovered a phagocytic gene network that is repressed by DNA methylation in monocytes and rapidly de-repressed after the onset of macrophage differentiation.
Genome Biology and Evolution | 2014
Katrin Rademacher; Christopher Schröder; Deniz Kanber; Ludger Klein-Hitpass; Stefan Wallner; Michael Zeschnigk; Bernhard Horsthemke
Imprinting of the human RB1 gene is due to the presence of a differentially methylated CpG island (CGI) in intron 2, which is part of a retrocopy derived from the PPP1R26 gene on chromosome 9. The murine Rb1 gene does not have this retrocopy and is not imprinted. We have investigated whether the RB1/Rb1 locus is unique with respect to these differences. For this, we have compared the CGIs from human and mouse by in silico analyses. We have found that the human genome does not only contain more CGIs than the mouse, but the proportion of intronic CGIs is also higher (7.7% vs. 3.5%). At least 2,033 human intronic CGIs are not present in the mouse. Among these CGIs, 104 show sequence similarities elsewhere in the human genome, which suggests that they arose from retrotransposition. We could narrow down the time points when most of these CGIs appeared during evolution. Their methylation status was analyzed in two monocyte methylome data sets from whole-genome bisulfite sequencing and in 18 published methylomes. Four CGIs, which are located in the RB1, ASRGL1, PARP11, and PDXDC1 genes, occur as methylated and unmethylated copies. In contrast to imprinted methylation at the RB1 locus, differential methylation of the ASRGL1 and PDXDC1 CGIs appears to be sequence dependent. Our study supports the notion that the epigenetic fate of the retrotransposed DNA depends on its sequence and selective forces at the integration site.
workshop on algorithms in bioinformatics | 2016
Christopher Schröder; Sven Rahmann
Mixtures of beta distributions have previously been shown to be a flexible tool for modeling data with values on the unit interval, such as methylation levels. However, maximum likelihood parameter estimation with beta distributions suffers from problems because of singularities in the log-likelihood function if some observations take the values 0 or 1. While ad-hoc corrections have been proposed to mitigate this problem, we propose a different approach to parameter estimation for beta mixtures where such problems do not arise in the first place. Our algorithm has computational advantages over the maximum-likelihood-based EM algorithm. As an application, we demonstrate that methylation state classification is more accurate when using adaptive thresholds from beta mixtures than non-adaptive thresholds on observed methylation levels.
Epigenetics & Chromatin | 2017
Christopher Schröder; Elsa Leitão; Stefan Wallner; Gerd Schmitz; Ludger Klein-Hitpass; Anupam Sinha; Karl-Heinz Jöckel; Stefanie Heilmann-Heimbach; Per Hoffmann; Markus M. Nöthen; Michael Steffens; Peter Ebert; Sven Rahmann; Bernhard Horsthemke
BackgroundThere is increasing evidence for inter-individual methylation differences at CpG dinucleotides in the human genome, but the regional extent and function of these differences have not yet been studied in detail. For identifying regions of common methylation differences, we used whole genome bisulfite sequencing data of monocytes from five donors and a novel bioinformatic strategy.ResultsWe identified 157 differentially methylated regions (DMRs) with four or more CpGs, almost none of which has been described before. The DMRs fall into different chromatin states, where methylation is inversely correlated with active, but not repressive histone marks. However, methylation is not correlated with the expression of associated genes. High-resolution single nucleotide polymorphism (SNP) genotyping of the five donors revealed evidence for a role of cis-acting genetic variation in establishing methylation patterns. To validate this finding in a larger cohort, we performed genome-wide association studies (GWAS) using SNP genotypes and 450k array methylation data from blood samples of 1128 individuals. Only 30/157 (19%) DMRs include at least one 450k CpG, which shows that these arrays miss a large proportion of DNA methylation variation. In most cases, the GWAS peak overlapped the CpG position, and these regions are enriched for CREB group, NF-1, Sp100 and CTCF binding motifs. In two cases, there was tentative evidence for a trans-effect by KRAB zinc finger proteins.ConclusionsAllele-specific DNA methylation occurs in discrete chromosomal regions and is driven by genetic variation in cis and trans, but in general has little effect on gene expression.
Archive | 2016
Stefan Wallner; Christopher Schröder; Elsa Leitão; Tea Berulava; Claudia Haak; Daniela Beißer; Sven Rahmann; Andreas S. Richter; Thomas Manke; Ulrike Bönisch; Laura Arrigoni; Sebastian Fröhler; Filippos Klironomos; Wei Chen; Nikolaus Rajewsky; Fabian Müller; Peter Ebert; Thomas Lengauer; Matthias Barann; Philip Rosenstiel; Gilles Gasparoni; Karl Nordström; Jörn Walter; Benedikt Brors; Gideon Zipprich; Bärbel Felder; Ludger Klein-Hitpass; Corinna Attenberger; Gerd Schmitz; Bernhard Horsthemke
Additional file 11: Table S5. Overview over the donors and sample nomenclature used in the analyses presented in the manuscript.
Archive | 2017
Johannes Köster; Christopher Schröder; Patrick Marks; Sitag; Sofia Panagiotopoulou; Fedor Gusev; Tomáš Gavenčiak; Rizky Luthfianto; Paul Ryvkin; David Laehnemann; Arno; Andrelmartins
Algorithms for Molecular Biology | 2017
Christopher Schröder; Sven Rahmann
Archive | 2016
Stefan Wallner; Christopher Schröder; Elsa Leitão; Tea Berulava; Claudia Haak; Daniela Beißer; Sven Rahmann; Andreas S. Richter; Thomas Manke; Ulrike Bönisch; Laura Arrigoni; Sebastian Fröhler; Filippos Klironomos; Wei Chen; Nikolaus Rajewsky; Fabian Müller; Peter Ebert; Thomas Lengauer; Matthias Barann; Philip Rosenstiel; Gilles Gasparoni; Karl Nordström; Jörn Walter; Benedikt Brors; Gideon Zipprich; Bärbel Felder; Ludger Klein-Hitpass; Corinna Attenberger; Gerd Schmitz; Bernhard Horsthemke
PeerJ | 2015
Christopher Schröder; Sven Rahmann